| Overview |
| bsm-61352r-cy3-100ul |
| Caveolin-3 Recombinant Antibody, Cy3 Conjugated |
| WB, IF |
| Human |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Caveolin 3 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 859 |
| P56539 |
| Cell membrane |
| CAV3; Caveolin 3; LGMD1C; LQT9; M-caveolin; VIP21. |
| May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. May also regulate voltage-gated potassium channels. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|
Powered by Bioz